China Extends EV Trade-In Subsidies Through 2026 to Boost Auto Sales
China confirms NEV trade-in subsidies for 2026, offering up to $2,850 per vehicle.
Already have an account? Sign in.
China confirms NEV trade-in subsidies for 2026, offering up to $2,850 per vehicle.
Abivax shares surge 4% on reports of Eli Lilly's €15B buyout interest. The French biotech's experimental ulcerative colitis drug obefazimod attracts big pharma attention after trial success.
Atara Biotherapeutics (ATRA) receives second FDA rejection for EBVALLO cancer therapy despite resolving manufacturing issues, citing concerns about clinical trial design.
Wolfe Research cuts Rivian to Underperform with a $16 target, citing weaker fundamentals, higher losses, and growing downside risks.